| Advances in cholangiocyte immunobiology G Syal, M Fausther, JA Dranoff American Journal of Physiology-Gastrointestinal and Liver Physiology, 2012 | 114 | 2012 |
| Safety of tofacitinib in a real-world cohort of patients with ulcerative colitis P Deepak, QA Alayo, A Khatiwada, B Lin, M Fenster, C Dimopoulos, ... Clinical Gastroenterology and Hepatology 19 (8), 1592-1601. e3, 2021 | 81 | 2021 |
| Ustekinumab is effective for the treatment of Crohn’s disease of the pouch in a multicenter cohort KN Weaver, M Gregory, G Syal, P Hoversten, SB Hicks, D Patel, ... Inflammatory bowel diseases 25 (4), 767-774, 2019 | 81 | 2019 |
| Efficacy of vedolizumab for refractory pouchitis of the ileo-anal pouch: results from a multicenter US cohort M Gregory, KN Weaver, P Hoversten, SB Hicks, D Patel, MA Ciorba, ... Inflammatory bowel diseases 25 (9), 1569-1576, 2019 | 67 | 2019 |
| Decreased antibody responses to Ad26. COV2. S relative to SARS-CoV-2 mRNA vaccines in patients with inflammatory bowel disease V Pozdnyakova, GJ Botwin, K Sobhani, J Prostko, J Braun, ... Gastroenterology 161 (6), 2041-2043. e1, 2021 | 34 | 2021 |
| Real-world effectiveness and safety of tofacitinib in crohn’s disease and IBD-U: a multicenter study from the TROPIC consortium M Fenster, QA Alayo, A Khatiwada, W Wang, C Dimopoulos, A Gutierrez, ... Clinical Gastroenterology and Hepatology 19 (10), 2207-2209. e3, 2021 | 25 | 2021 |
| AGA clinical practice guideline on the management of pouchitis and inflammatory pouch disorders EL Barnes, M Agrawal, G Syal, AN Ananthakrishnan, BL Cohen, ... Gastroenterology 166 (1), 59-85, 2024 | 19 | 2024 |
| Hypoalbuminemia and bandemia predict failure of infliximab rescue therapy in acute severe ulcerative colitis G Syal, L Robbins, A Kashani, N Bonthala, E Feldman, P Fleshner, ... Digestive Diseases and Sciences 66, 199-205, 2021 | 19 | 2021 |
| Pre-pouch ileitis is associated with development of Crohn’s disease-like complications and pouch failure G Syal, R Shemtov, N Bonthala, EA Vasiliauskas, EJ Feldman, ... Journal of Crohn's and Colitis 15 (6), 960-968, 2021 | 18 | 2021 |
| Fecal microbiota transplantation in inflammatory bowel disease: a primer for internists G Syal, A Kashani, DQ Shih The American Journal of Medicine 131 (9), 1017-1024, 2018 | 18 | 2018 |
| Effect of obesity on risk of hospitalization, surgery, and serious infection in biologic-treated patients with inflammatory bowel diseases: a CA-IBD cohort study P Gu, J Luo, J Kim, P Paul, B Limketkai, JS Sauk, S Park, N Parekh, ... Official journal of the American College of Gastroenterology| ACG 117 (10 …, 2022 | 17 | 2022 |
| Recurrent obstructive giant inflammatory polyposis of the colon G Syal, V Budhraja ACG Case Reports Journal 3 (1), e89, 2016 | 16 | 2016 |
| Comparative safety and effectiveness of biologic therapy for Crohn’s disease: a CA-IBD cohort study S Singh, J Kim, J Luo, P Paul, V Rudrapatna, S Park, K Zheng, G Syal, ... Clinical Gastroenterology and Hepatology 21 (9), 2359-2369. e5, 2023 | 15 | 2023 |
| P344 real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study R Ungaro, M Fenster, C Dimopoulos, A Patel, P Deepak, G Syal, A Yarur, ... Journal of Crohn's and Colitis 13 (Supplement_1), S274-S275, 2019 | 15 | 2019 |
| Preoperative serum vedolizumab levels do not impact postoperative outcomes in inflammatory bowel disease AB Parrish, NE Lopez, A Truong, K Zaghiyan, GY Melmed, ... Diseases of the Colon & Rectum 64 (10), 1259-1266, 2021 | 13 | 2021 |
| Gastric metastasis of merkel cell cancer--uncommon complication of a rare neoplasm G Syal, S Dang, J Rose, C Chen, F Aduli The Journal of Arkansas Medical Society 109 (7), 134-136, 2012 | 11 | 2012 |
| Postvaccination symptoms after a third dose of mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease: results from CORALE-IBD D Li, P Debbas, A Mujukian, S Cheng, J Braun, DPB McGovern, ... Inflammatory bowel diseases 29 (6), 883-887, 2023 | 10 | 2023 |
| Disease and treatment patterns among patients with pouch-related conditions in a cohort of large tertiary care inflammatory bowel disease centers in the United States EL Barnes, L Raffals, MD Long, G Syal, M Kayal, A Ananthakrishnan, ... Crohn's & Colitis 360 2 (3), otaa039, 2020 | 9 | 2020 |
| Health maintenance consensus for adults with inflammatory bowel disease G Syal, M Serrano, A Jain, BL Cohen, F Rieder, C Stone, B Abraham, ... Inflammatory Bowel Diseases 27 (10), 1552-1563, 2021 | 8 | 2021 |
| Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis M Akhlaghpour, T Haritunians, SK More, LS Thomas, DT Stamps, S Dube, ... Gut 72 (11), 2068-2080, 2023 | 7 | 2023 |
